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The generally employed assays for pig pancreatic kallikrein 
are based on the hydroly tic activity of the enzyme towards 
synthetic substrates or the natural substrate kininogen. None 
of these assays is specific for kallikrein since these substrates 
are hydrolyzed by other proteases, too. For physiological 
studies, which require the measurement of pig pancreatic 
kallikrein in tissues and body fluids, a more specific assay 
would be highly desirable. Since methods, based on immuno-
chemical properties can be expected to be highly specific we 
developed a radioimmunoassay. 
Purified pig pancreatic kallikrein [2] was labelled with 
iodine-125 employing the chloramine-T method [3] to a 
specific radioactivity of 80 uCi/ug. The labelled kallikrein was 
dilutedwithbufferA(0.015M N a H , P C V 0 . 1 5 M N a C l , 0 . 0 2 ° o 
Merthiolat, 0.2 ° 0 bovine serum albumin, 0.01 M E D T A . p H 
7.4) to a concentration of 250000 cpm ml, 70 ug ml of rabbit 
IgG were added. Anti-kallikrein serum produced in rabbits 
was diluted 1:300000 to 1:500000 with buffer B (composition 
like buffer A but 4% bovine serum albumin). Incubation 
conditions: 100 ul of buffer A , 100 ul of standard sample or 
unknown, 100 ul of antiserum dilution and 100 ul of tracer 
were incubated for 2 4 - 48 h at room temperature, then 100 ul 
of anti-rabbit IgG serum dilution and. after additional 2h, 
0.5 ml of buffer A were added. After centrifugation (10 min, 
6000 g) the supernatant w as aspirated and the radioactivity of 
the precipitates measured in a gamma counter. The assays 
were evaluated by the spline approximation method [4]. The 
lower detection limit is generally between 0.4 and 3 ng ml. The 
intraassay precision of quadruplicates is 6—10%. the in-
traassay precision of 5 consecutive assays was 6— 1 5 ° 0 . The 
specificity of the assay was examined by measuring the 
capacity of a series of serine protease to inhibit the binding of 
1 2 5 I-labelled kallikrein to the antibody. Porcine trypsin, 
bovine trypsin and chymotrypsin. guinea pig coagulation 
gland and submandibular gland kallikrein had no effect on 
the binding of 1 2 5 I -ka l l ikre in to the antibody whereas porcine 
urinary and porcine submandibular gland kallikreins showed 
an immunochemical reactivity identical with pig pancreatic 
kallikrein in the radioimmunoassay. 
The radioimmunoassay was employed to investigate 
whether pig pancreatic kallikrein is absorbed by the intestine. 
The ductus thoracicus of albino rats was canulated with a U -
like polyethylene tube [1] and the lymphatic fluid collected 
into tubes which were changed at regular intervals. After an 
initial control period 10mg of pig pancreatic kallikrein 
dissolved in 1 ml of 0.9 ° 0 saline were injected into the lumen of 
the duodenum. The fractions of lymphatic fluid collected for 
up to 6h after injection were examined for kallikrein by means 
of the radioimmunoassay. Kallikrein was detected in the 
samples within 4h in concentrations up to 200ng ml. Several 
samples of lymphatic fluid were subjected to gel filtration. 
When the eluate was checked by the radioimmunoassay two 
peaks of kallikrein were detected, one in the normal elution 
position of pig pancreatic kallikrein. the other in a position 
corresponding to a molecular weight of ^ 80000. These 
findings indicate that intact molecules of kallikrein are 
absorbed and that the absorbed kallikrein is partly bound to a 
plasma protein, presumably ai-antitrypsin. 
Since, under physiological conditions, pancreatic kallik-
rein is secreted into the duodenum from where it can be 
adsorbed, it seemed possible that pancreatic kallikrein might 
be present in blood. When be examined samples of pig serum 
by the radioimmunoassay we found kallikrein in concen-
trations up to 200 ng ml. If pig serum was subjected to gel 
filtration two peaks of kallikrein were detected in elution 
positions as described above for rat lymphatic fluid. 
These results demonstrate — to our knowledge for the 
first time —the presence of glandular kallikrein in blood. Its 
origin remains unclear since by our radioimmunoassay it is 
not possible to discriminate between the different glandular 
kallikreins. The question arises whether urinary kallikrein is 
synthesized by the kidney as generally assumed or whether it 
is only filtrated from the blood. 
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